Purpose
to support the development of a novel Ipa protein/LPS O-antigen-based glycoconjugate vaccines against shigellosis
Grantee
Division
Global Health
Date
MARCH 2020
Region served
GLOBAL
Committed amount
$205,713
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
9
Grantee location
Lawrence, Kansas, United States
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.